| Literature DB >> 27030717 |
Xin Luo1, Wai L Tai1, Liting Sun1, Zhiqiang Pan2, Zhengyuan Xia3, Sookja K Chung4, Chi Wai Cheung5.
Abstract
<span class="abstract_title">BACKGROUND: Chemokine axis <span class="Gene">chemokine C-X-C motif ligand 12/C-X-C chemokine receptor type 4 (CXCL12/CXCR4) is an emerging pain modulator, but mechanisms for its involvement in neuropathic pain remain unclear. Here, we aimed to study whether CXCL12/CXCR4 axis modulated the development of neuropathic pain via glial mechanisms. In this study, two mouse models of neuropathic pain, namely partial sciatic nerve ligation (pSNL) model and chronic post-ischemia pain (CPIP) model, were used.Entities:
Keywords: CXCL12/CXCR4 axis; glial–glial crosstalk; neuroinflammation; neuropathic pain
Mesh:
Substances:
Year: 2016 PMID: 27030717 PMCID: PMC4956184 DOI: 10.1177/1744806916636385
Source DB: PubMed Journal: Mol Pain ISSN: 1744-8069 Impact factor: 3.395
Figure 1.Mechanical allodynia developed in pSNL- or CPIP-injured mice. The PWT of mice was decreased in the pSNL model (a) and the CPIP model (b) as determined by the von Frey test. Results are means ± SEM (n = 5–6). ***p < 0.001 and *p < 0.05 versus the baseline and ###p < 0.001 versus data on POD 7 from the same group.
pSNL: partial sciatic nerve ligation; CPIP: chronic post-ischemia pain; PWT: paw withdrawal threshold; POD: post-operative day.
Figure 2.Expression and distribution of CXCL12/CXCR4 axis in L3–L5 segment of spinal cord in normal mice. In the spinal cord dorsal horn, CXCL12 (green) and CXCR4 (green) were co-expressed with IBA1 (red) and GFAP (red). High-resolution images were shown in boxes, the co-expression was marked with arrows, and nuclear was marked with blue (original magnification: 200×, scale bar = 100 µm).
CXCL12/CXCR4: chemokine C-X-C motif ligand 12/C-X-C chemokine receptor type 4; GFAP: glial fibrillary acidic protein; IBA1: ionized calcium binding adaptor molecule 1.
Figure 3.Expression pattern of CXCL12 in ipsilateral L3–L5 segment of spinal cord in the pSNL or CPIP model. (a) The immunoreactivity of GFAP (red) and CXCL12 (green) were increased in the ipsilateral lumbar spinal cord of pSNL-injured and CPIP-injured mice on POD 3, which was summarized in (b) and (c). Original magnification: 200× for all the confocal images (Bar = 100 µm). (d) TNF-α increased the mRNA levels of CXCL12 in astrocyte in vitro. Results are means ± SEM (n = 3). ***p < 0.001, **p < 0.01 and *p < 0.05 versus sham group. ###p < 0.001 versus TNF-α 0 ng group. CXCL12: chemokine C-X-C motif ligand 12; GFAP: glial fibrillary acidic protein; pSNL: partial sciatic nerve ligation; CPIP: chronic post-ischemia pain; POD: post-operative day; TNF-α: tumor necrosis factor alpha.
Figure 4.Cellular mechanisms accounting for CXCL12/CXCR4 axis-mediated nociception in naïve mice. The co-treatment of CXCL12 with AMD3100 and minocycline, but not fluorocitrate, prevented CXCL12-induced mechanical allodynia. Results are means ± SEM (n = 6–8). ***p and ###p < 0.001, *p < 0.05 versus the baseline.
CXCL12/CXCR4: chemokine C-X-C motif ligand 12/C-X-C chemokine receptor type 4; DMSO: dimethyl sulfoxide.
Figure 5.Effects of intrathecal injection of two CXCR4 antagonists on motor function in naïve mice. The falling latency of mice were not affected by intrathecal AMD3100, AMD3465, or saline. Results are means ± SEM (n = 5–6).
CXCR4: C-X-C chemokine receptor type 4.
Figure 6.Effects of intrathecal AMD3100 or AMD3465 on the development of mechanical allodynia in the pSNL model. The PWT of pSNL-injured mice was increased by intrathecal AMD3100 and AMD3465 in the ipsilateral (a) but not the contralateral (b) hindpaws as compared to the saline group. Results are means ± SEM (n = 6–10). ***p, ###p, and ψψψp < 0.001 and #p < 0.05 versus the baseline. aaap and bbbp < 0.001, bbp < 0.01 and bp < 0.05 versus the saline group.
pSNL: partial sciatic nerve ligation; POD: post-operative day; PWT: paw withdrawal threshold.
Figure 7.Effects of intrathecal AMD3100 on the spinal production of pain molecules in the pSNL model. After pSNL-injured mice receiving the intrathecal injection of AMD3100 (n = 8) or saline (n = 6), the lumbar spinal cord tissue was harvested on POD 3, and pain molecule levels were assessed by the real-time PCR test, including pro-inflammatory cytokines (a) and neuropeptides (b). Results are means ± SEM (n = 6–8). ###p < 0.001, aap < 0.01, ap < 0.05 versus the contralateral data in the saline group. bp < 0.05 versus the contralateral data in AMD3100 group. *p < 0.05 versus the ipsilateral data in the saline group.
TNF-α: tumor necrosis factor alpha; IL-6: interleukin 6; IL-1β: interleukin 1-beta; pSNL: partial sciatic nerve ligation; POD: post-operative day.
Figure 8.Effects of intrathecal AMD3100 or AMD3465 on the development of mechanical allodynia in the CPIP model. The PWT of CPIP mice was increased by intrathecal AMD3100 and AMD3465 in the ipsilateral (a) but not the contralateral (b) hindpaws as compared to the saline group. Results are means ± SEM (n = 6–10). Results are means ± SEM (n = 6–9). ***p, ###p, and ψψψp < 0.001 and **p < 0.01 versus the baseline. bbbp < 0.001, aap < 0.01, and ap < 0.05 versus the saline group.
CPIP: chronic post-ischemia pain; POD: post-operative day; PWT: paw withdrawal threshold.
Figure 9.Effects of intrathecal AMD3100 on the spinal production of pain molecules in the CPIP model. After IR-injured mice receiving the intrathecal injection of AMD3100 (n = 8) or saline (n = 6), the lumbar spinal cord tissue was harvested on POD 3, and the levels of pain molecules were assessed by real-time PCR test, including pro-inflammatory cytokines (a) and neuropeptides (b). Results are means ± SEM (n = 6–8). #p < 0.05 and ap < 0.05 versus the contralateral data in the saline group. bp < 0.05 versus the contralateral data in AMD3100 group. *p < 0.05 versus the ipsilateral data in the saline group.
TNF-α: tumor necrosis factor alpha; IL-6: interleukin 6; IL-1β: interleukin 1-beta; CPIP: chronic post-ischemia pain; SP: substance P; CGRP: calcitonin gene-related peptide; PDYN: prodynorphin; IR: ischemia-and-reperfusion.
Figure 10.Proposed mechanisms for CXCL12/CXCR4 axis in the pathogenesis of pain hypersensitivity in the pSNL or CPIP model. pSNL injury or CPIP injury might facilitate the increase of CXCL12 in the spinal cord dorsal horn through an astrocyte-dependent manner. By binding to microglial CXCR4, CXCL12 might increase the production of pro-inflammatory cytokines in microglia and contribute to the development of neuropathic pain.
CXCL12/CXCR4: chemokine C-X-C motif ligand 12/C-X-C chemokine receptor type 4; CPIP: chronic post-ischemia pain; pSNL: partial sciatic nerve ligation; TNF-α: tumor necrosis factor alpha; IL-1β: interleukin 1-beta; IL-6: interleukin 6.